Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation

<p>Overview of type of changes found in 12 target genes in 89 OL samples. Top: In the left graph the distribution of the classes of mutations is depicted. In the middle graph the type of variants is shown. In the right graph the nucleotide changes are indicated. Bottom: In the left graph the n...

Shranjeno v:

Bibliografske podrobnosti
Glavni avtor:	Leon J. Wils (15055780) (author)
Drugi avtorji:	Jos B. Poell (15055783) (author), Arjen Brink (15055786) (author), Ilkay Evren (15055789) (author), Elisabeth R. Brouns (15055792) (author), Jan G.A.M. de Visscher (15055795) (author), Elisabeth Bloemena (15055798) (author), Ruud H. Brakenhoff (15055801) (author)
Izdano:	2025
Teme:	Cancer Cancer Biology Tumor Biology Cancer Detection and Diagnosis Methods and Technology Cancer Prevention Epidemiology Biomarkers Genetic biomarkers Cancer risk assessment Carcinogenesis Premalignancy Computational Methods Sequence analysis Gene Technologies Mutation detection methods Genetics of Cancer Risk & Outcome Head, Neck & Oral Cancers Progression, Invasion & Metastasis Tumor progression
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
od: Leon J. Wils (15055780)
Izdano: (2025)

Supplementary Data 1 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Data 2 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Data 3 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Data 4 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Data 5 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Data 6 from The Mutational Landscape of Cancer's Vulnerability to Ionizing Radiation
od: Priyanka Gopal (15050862)
Izdano: (2025)

Supplementary Table S4 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
od: Chaoyang Zhang (15051876)
Izdano: (2025)

Supplementary Table S6 from Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
od: Chaoyang Zhang (15051876)
Izdano: (2025)

Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Supplementary Table S3 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Supplementary Table S5 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Supplementary Table S6 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
od: Raphaël Leman (17314506)
Izdano: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
od: Lenka Stolarova (16547259)
Izdano: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
od: Shuwei Li (16437116)
Izdano: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
od: Ismael Fernández-Miranda (15051932)
Izdano: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
od: Josephine K. Dermawan (17079555)
Izdano: (2025)

Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Figure 2 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Figure 3 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Figure 4 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Figure 5 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Supplementary Table 4: SpatialDecon derived immune cell counts from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Supplementry Table 3: REACTOME Gene Set Enrichment Analysis results from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Table 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
od: Colin S. Wood (15293247)
Izdano: (2025)

Supplementary table S2 from SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
od: Leon P. Loevenich (14963948)
Izdano: (2025)

Cannot write session to /tmp/vufind_sessions/sess_vfhmiukhlpo1386gn4sku0bqmm